We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

High-flow Conditioned Oxygen Therapy Versus Non-invasive Ventilation: Prevention of Post-extubation Failure

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01191489
First Posted: August 30, 2010
Last Update Posted: September 12, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Gonzalo Hernandez Martinez, Hospital Infanta Sofia
  Purpose
The main aim is to demonstrate whether the high flow conditioned oxygen therapy reduces the reintubation rate. Post-extubation respiratory failure risk will be stratified (as the randomization). In high risk patients high flow conditioned oxygen therapy will be compared with with not conditioned non-invasive mechanical ventilation. In low risk patients comparison will be conventional oxygen therapy. Hypercapnic patients will be excluded.

Condition Intervention Phase
Post-extubation Respiratory Failure Device: High Flow Conditioned Oxygen Therapy in High Risk Patients Device: Non-invasive mechanical ventilation Device: Conventional Oxygen Therapy Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Comparison Between High-flow Conditioned Oxygen Therapy and Non-invasive Ventilation in Prevention of Post-extubation Respiratory Failure. A Randomized Controlled Trial

Resource links provided by NLM:


Further study details as provided by Gonzalo Hernandez Martinez, Hospital Infanta Sofia:

Primary Outcome Measures:
  • Post-extubation respiratory failure and Reintubation rate [ Time Frame: 3 months ]

Secondary Outcome Measures:
  • Intensive Care Unit mortality rate [ Time Frame: 3 month ]
  • Hospital mortality rate [ Time Frame: 6 months ]
  • Intensive Care Unit length of stay [ Time Frame: 3 months ]
  • Hospital length of stay [ Time Frame: 6 months ]
  • Nosocomial pneumonia rate [ Time Frame: 3 months ]
  • Tracheobronchitis rate [ Time Frame: 3 months ]

Enrollment: 1042
Study Start Date: September 2012
Study Completion Date: September 2014
Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: High Flow Conditioned Oxygen Therapy in high risk patients Device: High Flow Conditioned Oxygen Therapy in High Risk Patients
OptiFlow system (R) with nasal cannula.
Active Comparator: Non-invasive mechanical ventilation in High Risk Patients Device: Non-invasive mechanical ventilation
Bilevel pressure support through a facial mask
Experimental: High Flow Conditioned Oxygen Therapy in Low Risk Patients Device: High Flow Conditioned Oxygen Therapy in High Risk Patients
OptiFlow system (R) with nasal cannula.
Active Comparator: Conventional Oxygen Therapy in Low Risk Patients Device: Conventional Oxygen Therapy
Conventional Oxygen Therapy with nasal cannula or Venturi facial mask.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Low Risk Patients:
  • Any extubated patients after tolerating a spontaneous breathing trial.
  • High Risk Patients:
  • Any extubated patients after >48 hours under mechanical ventilation and any of the following:
  • >65 years

    • cardiac failure as the primary indication of mechanical ventilation
    • COPD
    • APACHE II >12 points the extubation day
    • BMI >30
    • inability to manage respiratory secretions

      • 1 failed spontaneous breathing trial
      • 1 comorbidity
      • 7 days under mechanical ventilation

Exclusion Criteria:

  • <18 years
  • thacheotomized patients
  • recent facial or cervical trauma/surgery
  • active gastro-intestinal bleeding
  • lack of cooperation and patients with any failed spontaneous breathing trial because of hypercapnia development.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01191489


Locations
Spain
Hospital Infanta Sofia
San Sebastian de los Reyes, Madrid, Spain, 28703
Hospital General de Ciudad Real
Ciudad Real, Spain, 13005
Sponsors and Collaborators
Hospital Infanta Sofia
Investigators
Study Chair: Gonzalo Hernandez, MD Hospital Infanta Sofia